Houston Litigation Attorney:
Pharmaceutical Claims

Drugs and Medical Products Sometimes Cause Harm

The Gallagher Law Firm is currently focused on pharmaceutical cases involving harm or illnesses caused by:

  • Actos – a drug to treat type 2 diabetes related to bladder cancer (see also Actos bladder cancer lawsuit)
  • Pradaxa — an anticoagulant used to prevent stroke in patients with non-valvular atrial fibrillation
  • Reglan – a drug used to treat digestive issues associated with diabetes & chemotherapy
  • Darvocet – a narcotic pain reliever
  • Accutane – an acne medication
  • Fosamax – a medication for osteoporosis
  • Yaz – a common birth control medication
  • Crestor – a widely used cholesterol medication
  • Zoloft – a commonly used anti-depressant: (see also Zoloft birth defect lawsuit)
  • Transvaginal Mesh – medical device for surgical repair (see also Transvaginal mesh lawsuit)
  • Xarelto – an oral anticoagulant used to treat and prevent blood clots
  • Bard® IVC Filter – a type of vascular filter used to prevent pulmonary emboli
  • Invokana – an oral medicine that treats type 2 diabetes

If you suspect that you or a friend or family member has been injured by either of these drugs, please call the Gallagher Law Firm at (713) 238-7705 for a free in-office consultation to learn about your rights and the potential for compensation.

Related Press:

“American Home Settlement May Hamper Merger” – The Wall Street Journal

“Grand Jury Probes American Home on Reporting of Drugs’ Side Effects” – The Wall Street Journal

“Fen-Phen Firm Settles Suit After Verdict” – Dallas Morning News

“I think it is irresponsible to try and extend liability beyond those areas that are scientifically justifiable and defensible, and good lawyers will stay within those parameters. In that fashion, you do your client a service, and you do the legal profession a service.” – Mike Gallagher

Mr. Gallagher is currently representing plaintiffs in cases pertaining to such drugs as Trasylol, Vioxx, Zyprexa and Seroquel and the firm also regularly monitors the pharmaceutical industry to identify unreasonably dangerous drugs that are removed, or have the potential to be removed, from the market.